SBP solbec pharmaceuticals limited

genentech up $11 billion, page-8

  1. 796 Posts.
    lightbulb Created with Sketch. 27
    Not necessarily the strongest absolute response. The most rational target could be the one where the difference in efficacy between Coramsine and the current best treatment is greatest. This presumably needs also to be blended with market potential to arrive at the optimal target.
 
watchlist Created with Sketch. Add SBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.